As IL-6 inhibition comes into practice for PMR, research advances on other therapeutic mechanisms of action, from IL-17 to ...

Initiating add-on therapy within 2 years of a myasthenia gravis (MG) diagnosis was associated with a stronger and more consistent clinical response, according to a new study published in the Journal ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Cluster headache, while rare, can be treated in primary ...

Comparable long-term effectiveness to classic corticosteroids, both prednisone (p=0.8587) and deflazacort (p=0.6544), based on time to loss of ambulation80% fewer patients with vertebral fractures (8.

The addition of Zytiga (abiraterone) to Truqap (capivasertib) significantly prolonged radiographic progression-free survival (rPFS) in patients with PTEN-deficient metastatic hormone-sensitive ...

Comparable long-term effectiveness to classic corticosteroids, both prednisone (p=0.8587) and deflazacort (p=0.6544), based on time to loss of ...

Anifrolumab yielded positive outcomes, including remission in 26% of patients, at 6 months across a real-word, multicenter cohort of patients with systemic lupus erythematosus, according to data ...

Much of the advice about improving sleep focuses on what to do shortly before you go to bed. Turn down the lights, stop ...

He is the lead principal investigator of the ALLEGORY study and the lead author and he has also presented the results last Friday at SLEuro. Today, Dr. Richard Furie will take us again through the ...

A 55-year-old man developed painful swelling that doctors later thought was arthritis. Subtle clues revealed something more ...

Niraparib and abiraterone acetate regimen demonstrates clinically meaningful delay in disease progression, nearly halving the risk of progression or death, with an early trend toward improved overall ...

Phase III results put obinutuzumab in line for approval ...